A detailed history of Fox Run Management, L.L.C. transactions in Xencor Inc stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 12,656 shares of XNCR stock, worth $291,973. This represents 0.06% of its overall portfolio holdings.

Number of Shares
12,656
Previous 20,111 37.07%
Holding current value
$291,973
Previous $380,000 33.16%
% of portfolio
0.06%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$15.7 - $21.65 $117,043 - $161,400
-7,455 Reduced 37.07%
12,656 $254,000
Q2 2024

Aug 13, 2024

BUY
$18.21 - $24.5 $366,221 - $492,719
20,111 New
20,111 $380,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.38B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.